immunohub

Is an online platform that provides timely, reliable guidance for frontline providers and urgent care teams on the initial management of patients receiving CAR-T or bispecific T-cell engager therapy who may be experiencing related side effects.

Our Vision at ImmunoHub

We believe a treatment’s success depends not only on its efficacy but also on its accessibility. Our goal is to help immunotherapies reach the patients who need them while ensuring they receive proper care when complications arise. By providing timely guidance, ImmunoHub bridges the gap between effective treatments and effective management to improve patient outcomes.

Patient Peace of Mind

ImmunoHub empowers patients by ensuring that, no matter where they are, healthcare providers can quickly access critical information to manage complications related to their immunotherapy. With a simple QR code scan from a patient’s alert bracelet, providers receive specific guidance—offering patients peace of mind and improving their quality of life. Whether in a clinic or urgent care setting, ImmunoHub ensures timely, informed care is always within reach.

Support for Frontline Providers

ImmunoHub helps providers navigate the complexities of evolving immunotherapies and their complications. When treating patients with side effects related to these agents, providers can instantly access concise, therapy-specific guidance for initial management. By offering clear, actionable steps, ImmunoHub helps identify problems early and help stabilize patients on a timely manner to reduce symptom escalation and help improve outcomes.

testimonial

"Living with cancer is hard enough, I don’t want the added worry of getting the proper care in an emergency. With this bracelet, I know that doctors will have the guidance they need to treat me safely regardless of where I am."

Patient on bispecific treatment
testimonial

"The platform linked to this bracelet gave me exactly what I needed—quick, clear guidance to treat the patient."

ER physician

This platform is intended to guide healthcare providers in the initial management of patients receiving immunotherapies such as bispecific T-cell engagers and CAR-T.
It does not replace clinical judgment, medical decision-making, or institutional policies.

Please contact the treating physician to establish a personalized plan of care.